Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to test the safety and effectiveness of oxaliplatin,
bevacizumab, and capecitabine given in combination with radiation therapy to see what effects
(good or bad) they have on patients with biliary tract and gallbladder cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Dana-Farber Cancer Institute Genentech, Inc. Hoffmann-La Roche Sanofi-Synthelabo